Suchergebnisse - "Scheetz, Marc H."

PubPharm (41)

1

Flucloxacillin worsens while imipenem-cilastatin protects against vancomycin-induced kidney injury in a translational rat model

enthalten in: British journal of pharmacology | 2024

von Pais, G. | Marianski, S. | Valdez, K. | +7

2

Individual meropenem epithelial lining fluid and plasma PK/PD target attainment

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Rohani, R. | Yarnold, P. | Scheetz, M. | +12

3

Population pharmacokinetic model of cefepime for critically ill adults : a comparative assessment of eGFR equations

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Barreto, E. | Chang, J. | Rule, A. | +7

4

Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group : A Narrative Review

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Doernberg, S. | Arias, C. | Altman, D. | +42

5

Making the case for precision dosing : visualizing the variability of cefepime exposures in critically ill adults

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Chang, J. | Liu, J. | Alshaer, M. | +5

6

Iohexol-Measured Glomerular Filtration Rate and Urinary Biomarker Changes between Vancomycin and Vancomycin Plus Piperacillin-Tazobactam in a Translational Rat Model

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Chang, J. | Pais, G. | Marianski, S. | +4

UpdateOf: bioRxiv. 2023 Mar 12;:. - PMID 36945555

7

Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study

enthalten in: Therapeutic drug monitoring | 2023

von Barreto, E. | Chitre, P. | Pine, K. | +12

8

A novel 4-cell in-vitro blood-brain barrier model and its characterization by confocal microscopy and TEER measurement

enthalten in: Journal of neuroscience methods | 2023

von Malik, J. | Fletcher, C. | Podany, A. | +5

9

Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Rohani, R. | Scheetz, M. | Donnelly, H. | +114

10

Does calculation method matter for targeting vancomycin area under the curve?

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Chang, J. | Patel, D. | Vega, A. | +3

1
2
3
4
5
Nächster »
[5]